青少年无形性关节炎的现实生活治疗:缓解是长期的吗?
Laura Trives-Folguera1, Ana Melissa Anzola1, Indalecio Monteagudo-Saéz1
1Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Reumatologia clinica
|October 5, 2025
概括
青春期异常性关节炎 (JIA) 患者经常实现长期缓解,近80%的患者维持了3年. 不接受全身治疗的患者中,稳定缓解更为常见.
科学领域:
- 儿科风湿病学 儿科风湿病学
- 免疫学 免疫学 免疫学
- 慢性疾病管理 慢性疾病管理
背景情况:
- 青少年异常性关节炎 (JIA) 是儿童残疾的主要原因.
- 实现稳定的缓解对于预防JIA患者的长期残疾至关重要.
研究的目的:
- 评估JIA患者队列中的缓解存活率.
- 确定影响JIA长期缓解的因素.
主要方法:
- 对JIA患者进行的观察性,回顾性,纵向性研究.
- 从临床缓解到第一次爆发或最后一次诊所访问的缓解存活率分析.
- 在COVID-19大流行期间,根据华莱士标准定义的稳定缓解.
- 根据治疗分类的患者:没有全身治疗,仅用甲状腺素或生物药物.
主要成果:
- 包括82名JIA患者;68.3%为女性,中位数发病年龄为4.49岁.
- 在JIA亚组中,缓解生存率没有显著差异.
- 近80%的患者在3年后保持缓解;68.3%在5年后保持缓解.
- 在大流行期间 (18个月) 稳定的缓解得到了69.5%的患者.
- 在没有全身治疗的患者中,稳定缓解的可能性更高 (p=0.015).
结论:
- 在现实世界JIA管理中观察到的长期缓解生存率.
- 近80%的人在3年后实现了稳定的缓解.
- 单独使用甲德治疗与更频繁的爆发有关.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
488
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
488
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
434
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
434
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
490
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
490
Classification of Illness
8.6K
The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
8.6K
Autoimmune Disorders
1.5K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
1.5K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


